glp-1 agonist equivalent doses Receptor Agonists: An Alternative for Rapid-Acting Insulin? GLP-1 medications are marketed to

Description

Companies are combining digital services, nutritional products, and behavior coaching to improve outcomes

Obesity is often defined by certain body mass index (BMI) metrics, but more generally, it is defined as bodily dysregulation, according to Lydia Alexander, MD, the president of the Obesity Medicine Association

Likewise, GLP-1RAs can lower postprandial glycemia predominantly by slowing gastric emptying and promoting weight loss [6, 7]

Abbreviations GLP-1: Glucagon-like peptide-1 GLP-1RA: Glucagon-like peptide-1 receptor agonist T2DM: Type-2 diabetes mellitus DPP-4: Dipeptidyl peptidase 4 HbA1c: Hemoglobin A1c NASH: Non-alcoholic steatohepatitis NAFLD: Non-alcoholic fatty liver disease Camp: Cyclic adenosine monophosphate PKA: Protein kinase A EPAC: Exchange protein directly activated by cAMP PI3K: Phosphoinositide 3-kinase PYY: Peptide YY CCK: Cholecystokinin GLUT4: Glucose transporter type 4 mTORC1: Mammalian target of rapamycin complex 1 References Ahrn B (2015) Hepato-incretin function of GLP-1: novel concept and target in type 1 diabetes